OTC·Surgical & Medical Instruments & Apparatus

IDXGINTERPACE BIOSCIENCES, INC.

INTERPACE BIOSCIENCES, INC. (IDXG) has delisting / deregistration notice, delinquent SEC filing, and auditor change flags.

Last filing: filing·May 12, 2026EDGAR ↗

IDXG Cash Runway

Months-of-runway analysis for IDXG, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on IDXG

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.